Director/PDMR Shareholding
30 June 2020 15:00 BST Transaction by Person Discharging Managerial ResponsibilitiesDisclosure under Article 19 of the EU Market Abuse Regulation AstraZeneca PLC (the Company) announces that, on 29 June 2020, it was notified by Pascal Soriot, Chief Executive Officer, that, on 29 June 2020, Mr Soriot ceased to be beneficially interested in 127,389 Ordinary Shares of $0.25 each in the Company, following the gift of those shares to family members for nil consideration. The attached notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives